C. Droz‐Perroteau
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions 5
- Geriatrics and Gerontology top 10%
- Internal Medicine top 10%
-
- Prostate Cancer Treatment and Research 11
-
- Atrial Fibrillation Management and Outcomes 12
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Heart Failure Treatment and Management 5
- Acute Myocardial Infarction Research 5
-
- Radiopharmaceutical Chemistry and Applications 6
-
- Inflammatory mediators and NSAID effects 6
- Co-authors
- Nicholas MooreR. LassallePatrick BlinS. LamarqueC. Dureau‐PourninPierre‐Olivier GirodetMathiéu MolimardS. Lignot
- Journals
- Circulation (2 papers)Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)
In The Last Decade
C. Droz‐Perroteau
61 papers receiving 863 citations
Peers
Comparison fields: 5 of 107
- Toxicology 59
- Geriatrics and Gerontology 52
- Internal Medicine 43
- Pulmonary and Respiratory Medicine 298
- Physiology 187
Countries citing papers authored by C. Droz‐Perroteau
This map shows the geographic impact of C. Droz‐Perroteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Droz‐Perroteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Droz‐Perroteau more than expected).
Fields of papers citing papers by C. Droz‐Perroteau
This network shows the impact of papers produced by C. Droz‐Perroteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Droz‐Perroteau. The network helps show where C. Droz‐Perroteau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Droz‐Perroteau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 51 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 11 | |
| 10 | Abstract 14523: Two-Year Benefit-Risk of Standard and Reduced Doses of Rivaroxaban versus Vitamin-K Antagonists in Non-Valvular Atrial Fibrillation: A Cohort Study in the French Nationwide Claims Database | 2018 | 1 |
| 11 | 2018 | 13 | |
| 12 | 2018 | 6 | |
| 13 | Abstract 20559: Effectiveness and Safety of Rivaroxaban 15 mg Compared With Vitamin K Antagonists in Very Elderly Patients With Atrial Fibrillation, a Matched Cohort Study in the French Nationwide Claims Database SNIIRAM | 2017 | 1 |
| 14 | 2016 | 199 | |
| 15 | 2014 | 1 | |
| 16 | 2013 | 4 | |
| 17 | 2013 | 35 | |
| 18 | 2009 | 22 | |
| 19 | 2008 | 19 | |
| 20 | 2007 | 29 |
About C. Droz‐Perroteau
C. Droz‐Perroteau is a scholar working on Toxicology, Cardiology and Cardiovascular Medicine and Family Practice, having authored 68 papers that have together received 872 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (12 papers), Prostate Cancer Treatment and Research (11 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (6 papers), Heart Failure Treatment and Management (5 papers), Acute Myocardial Infarction Research (5 papers) and Pharmacovigilance and Adverse Drug Reactions (5 papers). The work is most often cited by research in Toxicology (59 citations), Geriatrics and Gerontology (52 citations) and Internal Medicine (43 citations). C. Droz‐Perroteau has collaborated with scholars based in France, Canada and Belize. Frequent co-authors include Nicholas Moore, R. Lassalle, Patrick Blin, S. Lamarque, C. Dureau‐Pournin, Pierre‐Olivier Girodet, Mathiéu Molimard, S. Lignot, Jérémy Jové and Chantal Rahérison. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.